fusidic acid has been researched along with exudates in 4 studies
| Studies (fusidic acid) | Trials (fusidic acid) | Recent Studies (post-2010) (fusidic acid) | Studies (exudates) | Trials (exudates) | Recent Studies (post-2010) (exudates) |
|---|---|---|---|---|---|
| 1,742 | 117 | 344 | 18,030 | 500 | 9,619 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kamel, AGM; Koh, YT; Lim, VKE; Ng, PP; Norazah, A; Rohani, MY; Spencer, K; Zuridah, H | 1 |
| Kamel, AG; Lim, VK; Norazah, A; Rohani, MY | 1 |
| Alreshidi, MA; Mariana, NS | 1 |
| Lim, KT; Teh, CS; Thong, KL; Yusof, MY | 1 |
4 other study(ies) available for fusidic acid and exudates
| Article | Year |
|---|---|
Molecular fingerprinting of fusidic acid- and rifampicin-resistant strains of methicillin-resistant Staphylococcus aureus (MRSA) from Malaysian hospitals.
Topics: Anti-Bacterial Agents; DNA Fingerprinting; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Fusidic Acid; Humans; Malaysia; Methicillin Resistance; Microbial Sensitivity Tests; Rifampin; Staphylococcal Infections; Staphylococcus aureus | 2002 |
In-vitro activity of quinupristin/dalfopristin, levofloxacin and moxifloxacin against fusidic acid and rifampicin-resistant strains of methicillin-resistant Staphylococcus aureus (MRSA) from Malaysian hospitals.
Topics: Anti-Bacterial Agents; Aza Compounds; Disease Susceptibility; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Fusidic Acid; Humans; In Vitro Techniques; Levofloxacin; Malaysia; Methicillin Resistance; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines; Rifampin; Staphylococcus aureus; Virginiamycin | 2005 |
Increasing rate of detection of fusidic acid resistance in methicillin-resistant Staphylococcus aureus isolated from clinical samples in Malaysia.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Fusidic Acid; Humans; Malaysia; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections | 2011 |
Mutations in rpoB and fusA cause resistance to rifampicin and fusidic acid in methicillin-resistant Staphylococcus aureus strains from a tertiary hospital in Malaysia.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Drug Resistance, Multiple, Bacterial; Fusidic Acid; Malaysia; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Peptide Elongation Factor G; Rifampin; Staphylococcal Infections | 2014 |